In vitro activity of BMY-28100 against common isolates from pediatric infections.
The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric infections by standard agar dilution methodology. The effect of inoculum size on activity was also assessed. BMY-28100 was more active than cephalexin or cefaclor against all bacterial species tested.
D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001424:Bacterial Infections / Q000382:microbiology; D002511:Cephalosporins / Q000494:pharmacology*; D002648:Child; D006801:Humans; D008826:Microbial Sensitivity Tests; D000097670:Cefprozil
D002511:Cephalosporins; D000097670:Cefprozil